“Transcriptomic Profiling and In Silico Drug Repurposing Reveal BIRC5 and AURKA as Actionable Targets in Triple-Negative Breast Cancer” (2025) Bangladesh Journal of Medical Physics, 16(2), pp. 56–64. doi:10.3329/bjmp.v16i2.84807.